Quick Answer
VYNE Therapeutics Inc. reported Shares Outstanding of 33.32 million shares for fiscal year 2025.
VYNE Therapeutics Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 33.32M | +124.7% |
| 2024 | 14.83M | +5.2% |
| 2023 | 14.10M | +336.5% |
| 2022 | 3.23M | +8.5% |
| 2021 | 2.98M | -93.1% |
| 2020 | 43.21M | +373.7% |
| 2019 | 9.12M | -60.7% |
| 2018 | 23.23M | +338.5% |
| 2017 | 5.30M | +0.4% |
| 2016 | 5.28M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| June 30, 2025 | 19.77M | +36.0% | +23.9% |
| March 31, 2025 | 15.96M | +11.6% | +7.6% |
| December 31, 2024 | 14.83M | +5.2% | +0.5% |
| September 30, 2024 | 14.75M | +346.4% | +1.5% |
| June 30, 2024 | 14.54M | +342.8% | +1.6% |
| March 31, 2024 | 14.30M | +337.2% | +1.4% |
| December 31, 2023 | 14.10M | +336.5% | +326.6% |
| September 30, 2023 | 3.30M | -94.3% | +0.7% |
- VYNE Therapeutics Inc. showed an increase of +124.7% in Shares Outstanding compared to the prior fiscal year.
- Over the 2016–2025 period, VYNE Therapeutics Inc.’s shares outstanding has grown by 531.1% (from 5.28 million shares to 33.32 million shares).
- The most recent figure is from VYNE Therapeutics Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: